Scientific evidence suggests that selective IL-12/23 receptor antagonists are a robust and reliable therapeutic alternative for the management of this inflammatory bowel condition.
Post
Tag: interleukin-12/23 receptor antagonist
Scientific evidence suggests that selective IL-12/23 receptor antagonists are a robust and reliable therapeutic alternative for the management of this inflammatory bowel condition.